FDA OKs Fidaxomicin for C difficile in Children FDA OKs Fidaxomicin for C difficile in Children

The macrolide antibacterial is now approved in oral suspension and tablets for treatment of Clostridioides difficile-associated diarrhea (CDAD) in children aged 6 months and older.FDA Approvals
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Gastroenterology News Alert Source Type: news